Valacyclovir contraindications: Difference between revisions

Jump to navigation Jump to search
ShiSheng (talk | contribs)
Gerald Chi (talk | contribs)
mNo edit summary
Line 1: Line 1:
__NOTOC__
__NOTOC__
{{Valacyclovir}}
{{Valacyclovir}}
{{CMG}}
{{CMG}}; {{AE}} {{SS}}


==Contraindications==
==Contraindications==
Line 11: Line 11:
{{FDA}}
{{FDA}}


[[Category:Antiviral]]
[[Category:Antibiotics]]
[[Category:Wikinfect]]
[[Category:Wikinfect]]

Revision as of 23:21, 2 January 2014

Valacyclovir
VALTREX® FDA Package Insert
Description
Clinical Pharmacology
Microbiology
Indications and Usage
Contraindications
Warnings and Precautions
Adverse Reactions
Overdosage
Clinical Studies
Dosage and Administration
How Supplied
Labels and Packages

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Sheng Shi, M.D. [2]

Contraindications

VALTREX is contraindicated in patients who have had a demonstrated clinically significant hypersensitivity reaction (e.g., anaphylaxis) to valacyclovir, acyclovir, or any component of the formulation [see Adverse Reactions (6.3)].[1]

References

  1. "http://www.accessdata.fda.gov/drugsatfda_docs/label/2008/020487s014lbl.pdf" (PDF). External link in |title= (help)

Adapted from the FDA Package Insert.